The generation and management of its intellectual property represent relevant value drivers for Nerviano Medical Sciences.

A core asset of a proprietary portfolio of about one hundred patent cases (totaling more than 900 active patents) extensively covers, among others, novel and potent potent anticancer agents, low-molecular weight kinase inhibitors and innovativative technologies.

This portfolio is maintained by a dedicated in-house group of professionals and it is continuously enriched by filing new patent applications every year.